NCT04682691View on ClinicalTrials.gov

Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 5, 2024

Study Completion Date

February 22, 2024

Conditions
Gastric Residual Volume
Interventions
DRUG

Erythromycin (400mg)

oral Erythromycin (400mg)

DRUG

metoclopramide (10mg)

oral metoclopramide (10mg)

DIETARY_SUPPLEMENT

naturally flavored water

naturally flavored water

Trial Locations (1)

11451

Faculty of Medicine, Cairo University., Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04682691 - Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume | Biotech Hunter | Biotech Hunter